Cidara Therapeutics, Inc. (CDTX)
NASDAQ: CDTX · Real-Time Price · USD
64.13
-2.24 (-3.38%)
At close: Aug 25, 2025, 4:00 PM
64.40
+0.27 (0.42%)
After-hours: Aug 25, 2025, 5:30 PM EDT
Cidara Therapeutics Stock Forecast
Stock Price Forecast
The 10 analysts that cover Cidara Therapeutics stock have a consensus rating of "Strong Buy" and an average price target of $57, which forecasts a -11.12% decrease in the stock price over the next year. The lowest target is $35 and the highest is $75.
Price Target: $57 (-11.12%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Cidara Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 |
---|---|---|---|---|---|---|
Strong Buy | 4 | 4 | 4 | 6 | 6 | 7 |
Buy | 4 | 4 | 4 | 5 | 5 | 4 |
Hold | 0 | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 8 | 8 | 8 | 11 | 11 | 11 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
JMP Securities | JMP Securities | Buy Maintains $59 → $66 | Buy | Maintains | $59 → $66 | +2.92% | Aug 8, 2025 |
Needham | Needham | Strong Buy Maintains $54 → $74 | Strong Buy | Maintains | $54 → $74 | +15.39% | Aug 8, 2025 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $53 → $74 | Strong Buy | Maintains | $53 → $74 | +15.39% | Aug 8, 2025 |
JMP Securities | JMP Securities | Buy Maintains $59 | Buy | Maintains | $59 | -8.00% | Jun 30, 2025 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $41 → $53 | Strong Buy | Maintains | $41 → $53 | -17.36% | Jun 24, 2025 |
Financial Forecast
Revenue This Year
n/a
from 1.28M
Revenue Next Year
4.59M
EPS This Year
-6.88
from -26.75
EPS Next Year
-8.15
from -6.88
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | n/a | 23.6M | 23.6M | ||
Avg | n/a | 4.6M | 5.7M | ||
Low | n/a | n/a | n/a |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | - | - | 414.7% | ||
Avg | - | - | 25.0% | ||
Low | - | - | - |
EPS Forecast
EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | -6.63 | -5.57 | -4.49 | ||
Avg | -6.88 | -8.15 | -6.96 | ||
Low | -7.02 | -13.24 | -7.97 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | - | - | - | ||
Avg | - | - | - | ||
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.